ResearcherHumboldt-Universität zu BerlinNo recent work listed

Ellen von Hoerschelmann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1082-2249; OpenAlex author ID A5078734724. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

Cancer Associated Fibroblasts Derived from Pancreatic Adenocarcinoma and Their Role in Cell Migration. Co-author DOI 10.21873/anticanres.15227 ↗
Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer. First author DOI 10.1016/j.hbpd.2018.09.004 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Marcus Bahra · 2 shared papers, 2018–2021 · strength 0.22
- Paper Cancer Associated Fibroblasts Derived from Pancreatic Adenocarcinoma and Their Role in Cell Migration. DOI 10.21873/anticanres.15227 ↗
- Paper Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer. DOI 10.1016/j.hbpd.2018.09.004 ↗
Rosa Bianca Schmuck · 2 shared papers, 2018–2021 · strength 0.22
- Paper Cancer Associated Fibroblasts Derived from Pancreatic Adenocarcinoma and Their Role in Cell Migration. DOI 10.21873/anticanres.15227 ↗
- Paper Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer. DOI 10.1016/j.hbpd.2018.09.004 ↗
Christopher Neumann · 2 shared papers, 2018–2021 · strength 0.22
- Paper Cancer Associated Fibroblasts Derived from Pancreatic Adenocarcinoma and Their Role in Cell Migration. DOI 10.21873/anticanres.15227 ↗
- Paper Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer. DOI 10.1016/j.hbpd.2018.09.004 ↗
Matthäus Felsenstein · 1 shared paper, 2021 · strength 0.13
- Paper Cancer Associated Fibroblasts Derived from Pancreatic Adenocarcinoma and Their Role in Cell Migration. DOI 10.21873/anticanres.15227 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.